{"DataElement":{"publicId":"7037390","version":"1","preferredName":"Laboratory Procedure Anti-Mullerian Hormone Lab Result Value","preferredDefinition":"Numeric value measuring the level of anti-mullerian hormone in the blood.","longName":"LAB_AMH_RSLT_VAL","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3346929","version":"1","preferredName":"Laboratory Procedure Anti-Mullerian Hormone Outcome","preferredDefinition":"information relating to the result of a laboratory procedure that involves testing a sample of blood for anti-mullerian hormone (a protein that is encoded by the AMH gene and inhibits the development of the MÃ¼llerian ducts).","longName":"2543047v1.0:3346927v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3346927","version":"1","preferredName":"Anti-Mullerian Hormone Receptor Type II Outcome","preferredDefinition":"Encoded by human AMHR2 Gene, the 573-amino acid 62.7 kD Anti-Mullerian Hormone Receptor Type II Ser/Thr protein kinase (TGFB Receptor Family) is a type I membrane protein.  Type II receptors bind ligand but require a type I receptor for signal transduction.  Anti-Mullerian Hormone (AMH/MIS/MIF), produced by Sertoli cells, induces regression of Mullerian ducts, which differentiate into the uterus and fallopian tubes.  Type I persistent Mullerian duct syndrome is caused by AMH gene mutation; type II syndrome is due to AMHR mutation.  (OMIM, Swiss-Prot, and NCI):The result of an action.","longName":"C21334:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-Muellerian Hormone Type-2 Receptor","conceptCode":"C21334","definition":"Anti-Muellerian hormone type-2 receptor (573 aa, ~63 kDa) is encoded by the human AMHR2 gene. This protein plays a role in signaling, serine/threonine phosphorylation and ligand binding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B61EBCA6-FAF6-5FA8-E040-BB89AD436C77","latestVersionIndicator":"Yes","beginDate":"2012-01-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-01-09","modifiedBy":"ONEDATA","dateModified":"2012-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B61EBCA6-FB07-5FA8-E040-BB89AD436C77","latestVersionIndicator":"Yes","beginDate":"2012-01-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-01-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7037388","version":"1","preferredName":"Lab Value","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A numerical quantity measured or assigned or computed.","longName":"UNSPEC_7_2_VAL","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":"2","maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208126","version":"1","preferredName":"Test Value","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.:A numerical quantity measured or assigned or computed.","longName":"C25294:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3EAA-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Princess Margaret Cancer Centre, Toronto, ON","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9649E8CB-C2A5-45C9-E053-F662850ADA0B","latestVersionIndicator":"Yes","beginDate":"2019-11-01","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-01","modifiedBy":"SOKKERL","dateModified":"2019-11-01","changeDescription":"11/1/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"AMH","type":"Preferred Question Text","description":"AMH","url":null,"context":"NCIP"}],"origin":"Princess Margaret Cancer Centre, Toronto, ON","workflowStatus":"RELEASED","registrationStatus":"Application","id":"964A227B-A939-45BD-E053-F662850A74F6","latestVersionIndicator":"Yes","beginDate":"2019-11-01","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-01","modifiedBy":"SOKKERL","dateModified":"2019-11-01","changeDescription":"11/1/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}